DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Rebetol (Ribavirin) - Pruritus - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pruritus (79)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Rebetol (Ribavirin) where reactions include pruritus. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 79   Next >>

Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-27

Patient:

Reactions: Fatigue, Vomiting, Pruritus, Diarrhoea, Dehydration, Ephelides

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Start date: 2012-03-24

Rebetol
    Dosage: 1200 mg, qd
    Administration route: Oral
    Start date: 2012-03-24

Victrelis
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Other drugs received by patient: Metformin HCL



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27

Patient:

Reactions: Pruritus, Nasopharyngitis, Feeling Hot

Drug(s) suspected as cause:
Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-15

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-15



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-25

Patient:

Reactions: Fatigue, Pruritus, Rash, Drug Abuse, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-05



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Pruritus, Anaemia, Chest Pain, DRY Skin, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram/0.5 ml, qw

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral

Other drugs received by patient: Vitamins (Unspecified); Cyanocobalamin; Tylenol; Telaprevir



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Pruritus, Hypersensitivity, Contusion, Chills, Headache, Herpes Zoster, Vascular Injury, Fatigue, Malaise, Tongue Disorder, Candidiasis, Scratch, Swelling Face, Vomiting, Tongue Oedema, Nausea, Anaemia, Hypoaesthesia, Rash, Dysgeusia, Diarrhoea, Feeling Abnormal, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-04

Valtrex
    Dosage: unk unk, unknown
    Indication: Herpes Zoster

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-06-01



Possible Rebetol side effects in

Reported by a pharmacist from United States on 2012-08-23

Patient:

Reactions: Pruritus, Diarrhoea, Urinary Incontinence

Drug(s) suspected as cause:
Pegasys

Rebetol
    Administration route: Oral

Victrelis
    Dosage: 4 df, tid
    Administration route: Oral



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Telaprevir
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-07

Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Renal Impairment, Pruritus, Anaemia, Rash, Hyperuricaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.027mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-09

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-09
    End date: 2012-04-15

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-06-18

Rebetol
    Dosage: 200 mg, once
    Administration route: Oral
    Start date: 2012-06-11
    End date: 2012-06-17

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-16
    End date: 2012-06-10

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Other drugs received by patient: Voltaren; Voltaren-XR; Antebate



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-22

Patient:

Reactions: Tooth Fracture, Pruritus, Alcohol Abuse, Ejaculation Failure, Tooth Extraction, Psoriasis, Rash, Injection Site Erythema, Overdose, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-04-24

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-22



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Pruritus, Rash

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

PEG-Intron
    Dosage: 1.15 mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-11
    End date: 2012-05-09

Other drugs received by patient: Urso 250; Loxoprofen



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient:

Reactions: Weight Decreased, Pneumonia, Pruritus, Nausea, Pyrexia, Headache, Suicidal Ideation, Eating Disorder, Insomnia, Depression, Decreased Appetite, Candidiasis

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Dosage: 180 microgram, qw
    Indication: Hepatitis C
    Start date: 2011-08-19
    End date: 2012-04-18

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-19

Victrelis
    Dosage: 4 df, tid

Victrelis
    Dosage: 40 mg, tid
    Administration route: Oral

Victrelis
    Dosage: 800 mg, tid
    Indication: Hepatitis C
    Start date: 2011-09-16

Victrelis
    Dosage: unk, tid
    Start date: 2011-08-19

Other drugs received by patient: Atarax; Diuretic (Unspecified); Xanax



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04

Pegasys
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2005-04-01
    End date: 2006-03-03

Pegasys
    Dosage: unk
    Start date: 2012-03-22

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04

Rebetol
    Dosage: 3 df, qd
    Start date: 2012-03-22

Rebetol
    Dosage: unk
    Start date: 2005-04-01
    End date: 2006-03-03

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-19



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Germany on 2012-08-09

Patient:

Reactions: Aphthous Stomatitis, Stomatitis, Pruritus, Anaemia, Aggression, Middle Insomnia, Syncope, Mood Altered, NO Therapeutic Response, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 ?g, qw
    Start date: 2011-12-01

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

PEG-Intron
    Dosage: unk
    Start date: 2011-10-28
    End date: 2011-12-07

PEG-Intron
    Dosage: 64 ?g, qw

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2011-10-28

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral

Victrelis
    Dosage: 2400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-23

Other drugs received by patient: Opipramol Hydrochloride; Amitriptyline HCL; Citalopram Hydrobromide



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-07

Patient:

Reactions: White Blood Cell Count Decreased, Pruritus, Impaired Healing, Tooth Abscess, Skin Lesion, Tooth Extraction, Platelet Count Decreased, Memory Impairment

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-04

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-06-04

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-02



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Weight Decreased, Fatigue, Vomiting, Pruritus, Nausea, Chills, Urticaria, Asthenia, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-07-13

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-07-13

Other drugs received by patient: Zofran



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-08-06

Patient:

Reactions: Pruritus, Hepatic Neoplasm Malignant Recurrent

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 60 microgram, unk
    Start date: 2007-11-01

PEG-Intron
    Dosage: 60 microgram, unk
    Indication: Hepatitis C
    Start date: 2005-12-01

Rebetol
    Dosage: 200 mg, unk
    Indication: Hepatitis C
    Start date: 2005-12-01

Rebetol
    Dosage: 200 unk, unk
    Administration route: Oral
    Start date: 2005-11-01



Possible Rebetol side effects in

Reported by a consumer/non-health professional from United States on 2012-08-04

Patient:

Reactions: Pruritus, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: redipen
    Indication: Hepatitis C
    Start date: 2012-01-30

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-01-30

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-02-27



Possible Rebetol side effects in

Reported by a physician from United States on 2012-08-01

Patient:

Reactions: White Blood Cell Count Decreased, Pruritus, Pain, Platelet Count Decreased, Rash, Blister

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-19

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2011-08-19

Other drugs received by patient: Telaprevir



Possible Rebetol side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient:

Reactions: Pruritus, Eczema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fraxodi
    Dosage: unk
    Indication: Portal Vein Thrombosis
    Start date: 2012-03-07

Rebetol
    Dosage: 1000, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-02

Rebetol
    Dosage: 600 mg, qd
    Start date: 2012-01-02

Telaprevir
    Dosage: unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-02
    End date: 2012-03-25

Viraferonpeg
    Dosage: 0.4 unk, unk
    Indication: Hepatitis C
    Start date: 2012-01-02



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-30

Patient:

Reactions: Drug Eruption, Vomiting, Renal Impairment, Pruritus, Anaemia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.0mcg/kg
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-16

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-21

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-18

Other drugs received by patient: Biofermin (Bacillus Subtilis (+) Lactobacillus Acidophilus (+) Strepto; Norvasc; Maglax (Magnesium Oxide); Flavitan



Possible Rebetol side effects in

Reported by a physician from United States on 2012-07-19

Patient:

Reactions: Pruritus, Alcohol Abuse, Tooth Fracture, Ejaculation Failure, Tooth Extraction, Psoriasis, Rash, Overdose, Injection Site Erythema, Influenza

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-24

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-04-24

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-05-22



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-18

Patient:

Reactions: Dysgeusia, Drug Eruption, Hepatic Function Abnormal, Pruritus, Lymphadenopathy, Insomnia, Hyperuricaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Allopurinol
    Dosage: 100 mg, qd
    Administration route: Oral

Allopurinol
    Dosage: 200 mg, qd
    Administration route: Oral
    Indication: Adverse Event
    Start date: 2012-02-23

PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-05-20

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-05-20

Telaprevir
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-05-14

Other drugs received by patient: Rinderon V; [therapy Unspecified]; [therapy Unspecified]; Gasmotin; Marzulene-S; Clobetasol Propionate; Promac (Nitrofurantoin); [therapy Unspecified]; [therapy Unspecified]; Roxatidine Acetate HCL; Urso 250; Olopatadine HCL; Antebate; [therapy Unspecified]



Possible Rebetol side effects in

Reported by a individual with unspecified qualification from Germany on 2012-07-17

Patient:

Reactions: Aphthous Stomatitis, Pruritus, Stomatitis, Anaemia, Aggression, Middle Insomnia, Syncope, Mood Altered, NO Therapeutic Response, Thrombocytopenia, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Start date: 2011-10-28
    End date: 2011-12-07

PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

PEG-Intron
    Dosage: 80 a?g, qw
    Start date: 2011-12-01

PEG-Intron
    Dosage: 64 a?g, qw

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Start date: 2011-10-28

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2010-08-20
    End date: 2010-11-29

Victrelis
    Dosage: 2400 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-23

Other drugs received by patient: Opipramol Hydrochloride; Citalopram Hydrobromide; Amitriptyline HCL



Possible Rebetol side effects in

Reported by a physician from Japan on 2012-07-17

Patient:

Reactions: Retinopathy, Pruritus, Proteinuria, Pyrexia, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Interferon Beta NOS
    Start date: 2011-02-14
    End date: 2011-03-11

Interferon Beta NOS
    Start date: 2011-05-01
    End date: 2011-05-07

Interferon Beta NOS
    Start date: 2011-05-08
    End date: 2011-11-21

Interferon Beta NOS
    Start date: 2011-03-14
    End date: 2011-04-30

Interferon Beta NOS
    Indication: Hepatitis C
    Start date: 2010-11-30
    End date: 2011-02-12

Rebetol
    Dosage: 200 mg in the morning and 400 mg in the evening
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-11-30
    End date: 2011-11-21

Other drugs received by patient: Livact; Basen; Alfarol; Alendronate Sodium; Novorapid



Possible Rebetol side effects in 50 year old male

Reported by a physician from Japan on 2012-07-05

Patient: 50 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Weight Decreased, Drug Eruption, Pruritus, Pyrexia, Headache, Somnolence, Erythema, Treatment Noncompliance, Hyperuricaemia, Malaise, Abdominal Distension, Decreased Appetite, Dyspnoea, Nausea, Rash, Haemoglobin Decreased, Insomnia, Hypophagia, Gait Disturbance

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5;1.3 mcg/kg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-02-28
    End date: 2012-03-06

PEG-Intron
    Dosage: 1.5;1.3 mcg/kg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-03-13

PEG-Intron
    Dosage: 1.5;1.3 mcg/kg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-02-21

Rebetol
    Dosage: 800;600;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17

Rebetol
    Dosage: 800;600;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-27
    End date: 2012-04-09

Rebetol
    Dosage: 800;600;200 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-20
    End date: 2012-01-20

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-10

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-17
    End date: 2012-01-19

Telavic (Antivirals Nos)
    Dosage: 2250;1500 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-21
    End date: 2012-04-09

Other drugs received by patient: Confatanin; Famotidine; Famotidine; Xyzal; Clobetasol Propionate; Clobetasol Propionate; Confatanin



Possible Rebetol side effects in 54 year old female

Reported by a physician from Japan on 2012-07-05

Patient: 54 year old female, weighing 57.0 kg (125.4 pounds)

Reactions: Pruritus, Paraesthesia Oral, Rash, Erythema

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg;sc
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-06-09

Rebetol
    Dosage: 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-06-09

Telavic (Antivirals Nos)
    Dosage: 2250 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-05
    End date: 2012-06-09

Other drugs received by patient: Candesartan Cilexetil; Selbex



Possible Rebetol side effects in 52 year old female

Reported by a physician from France on 2012-07-05

Patient: 52 year old female

Reactions: Lymphadenopathy, Pruritus, Conjunctivitis, Skin Burning Sensation, Pancytopenia, Pyrexia, Eczema, Face Oedema, Dyspnoea Exertional, Asthenia, Dermatitis Exfoliative

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paroxetine HCL
    Dosage: 1 df, qd, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-05-15

Rebetol
    Dosage: 1000;800 mg, qd
    Indication: Hepatitis C
    Start date: 2012-05-02

Rebetol
    Dosage: 1000;800 mg, qd
    Indication: Hepatitis C
    Start date: 2012-01-02

Victrelis
    Dosage: 800 mg, qd, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-30
    End date: 2012-05-15

Viraferonpeg
    Dosage: 100;80 mcg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-05-02

Viraferonpeg
    Dosage: 100;80 mcg, qw, sc
    Indication: Hepatitis C
    Start date: 2012-01-02

Xanax
    Dosage: 0.50 mg, qd, po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-01
    End date: 2012-05-15

Other drugs received by patient: Escitalopram; Clobazam; Imovane



Possible Rebetol side effects in 63 year old female

Reported by a physician from Japan on 2012-07-05

Patient: 63 year old female, weighing 45.0 kg (99.0 pounds)

Reactions: Hepatic Function Abnormal, Pruritus, Vomiting, Nausea, Anaemia, Alanine Aminotransferase Increased, Rash, Pyrexia, Hyperuricaemia, Aspartate Aminotransferase Increased, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-02-09

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-09
    End date: 2012-03-07

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-08
    End date: 2012-04-19

Rebetol
    Dosage: 600 mg;qd;po 200 mg;qd;po 400 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-21

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-09
    End date: 2012-03-02

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-30
    End date: 2012-04-19

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po 1500 mg;qd;po 1000 mg;qd;po 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-08
    End date: 2012-03-29

Other drugs received by patient: Rabeprazole Sodium; Allopurinol; Celestamine TAB



Possible Rebetol side effects in 67 year old male

Reported by a physician from Japan on 2012-07-03

Patient: 67 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Pruritus, Anaemia, Platelet Count Decreased, Rash, Pyelonephritis

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg;sc ; 1.5 mcg/kg;sc
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-14

PEG-Intron
    Dosage: 1.5 mcg/kg;sc ; 1.5 mcg/kg;sc
    Indication: Hepatitis C
    Start date: 2012-04-04

Rebetol
    Dosage: 800 mg;qd;po ; 800 mg;qd;po ; 600 mg;qd;po ; 400 mg;qd;po ; 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-04
    End date: 2012-05-01

Rebetol
    Dosage: 800 mg;qd;po ; 800 mg;qd;po ; 600 mg;qd;po ; 400 mg;qd;po ; 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-23

Rebetol
    Dosage: 800 mg;qd;po ; 800 mg;qd;po ; 600 mg;qd;po ; 400 mg;qd;po ; 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-08

Rebetol
    Dosage: 800 mg;qd;po ; 800 mg;qd;po ; 600 mg;qd;po ; 400 mg;qd;po ; 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-22

Rebetol
    Dosage: 800 mg;qd;po ; 800 mg;qd;po ; 600 mg;qd;po ; 400 mg;qd;po ; 600 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-09
    End date: 2012-05-22

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po ; 1500 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-04
    End date: 2012-05-30

Telavic (Antivirals Nos)
    Dosage: 1500 mg;qd;po ; 1500 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-06
    End date: 2012-03-22

Other drugs received by patient: Ferotym; Epadel S; Claritin Reditabs; Livalo



Possible Rebetol side effects in 62 year old male

Reported by a physician from Japan on 2012-07-02

Patient: 62 year old male

Reactions: Oral Discomfort, Pruritus, Rash, Blood Creatinine Increased, Hyperuricaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 mcg/kg; qw; sc; 1.3 mcg/kg; qw; sc
    Indication: Hepatitis C
    Start date: 2012-03-05
    End date: 2012-04-16

PEG-Intron
    Dosage: 1.5 mcg/kg; qw; sc; 1.3 mcg/kg; qw; sc
    Indication: Hepatitis C
    Start date: 2012-04-23

Rebetol
    Dosage: 800 mg; qd; po, 400 mg; qd; po, 200 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-05
    End date: 2012-03-25

Rebetol
    Dosage: 800 mg; qd; po, 400 mg; qd; po, 200 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-26
    End date: 2012-04-08

Rebetol
    Dosage: 800 mg; qd; po, 400 mg; qd; po, 200 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-09

Telavic (Antivirals Nos)
    Dosage: 2250 mg; qd;po, 1500 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-05
    End date: 2012-05-01

Telavic (Antivirals Nos)
    Dosage: 2250 mg; qd;po, 1500 mg; qd; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-02
    End date: 2012-05-28

Other drugs received by patient: Zolpidem; Olopatadine HCL; Adalat CC; Livalo; Urso 250; Prednisolone; Candesartan Cilexetil



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017